INTRODUCTION
In reproductive medicine, couples with recurrent miscarriage (RM) and men with poor semen quality may undergo genetic testing as part of the diagnostic work-up. In couples with RM one of the partners may carry a balanced structural chromosome abnormality and their offspring is therefore at risk for unbalanced structural chromosome abnormalities leading to severe mental retardation and/or congenital malformations. The prevalence of a parental structural chromosome abnormality is estimated between 3% and 6%. [1] [2] [3] Clinical guidelines recommend parental karyotyping in couples with RM and subsequent invasive prenatal diagnosis when a chromosomal abnormality is found. [4] [5] [6] [7] Genetic testing in couples with RM is generally offered after two or three miscarriages.
Genetic testing in men with poor semen quality is generally performed if the total sperm count is < 1 million spermatozoa per ejaculate. Men undergo karyotyping and are evaluated for deletions on the Y-chromosome before starting with Intra Cytoplasmatic Sperm Injection (ICSI) treatment. A genetic cause is found in 10% to 15% of cases. 8 Men with a chromosomal abnormality have a higher risk of aneuploid offspring after ICSI treatment. In case of Y-deletions, all sons conceived by ICSI will inherit the same deletion with possible consequences for their reproductive chances. 9, 10 As with any other medical intervention, patients should be properly informed before undergoing genetic testing. It is health care professionals' duty to involve and support patients in rational decision making, since patients have the legal and ethical right to know what will happen to them. The information provided should at least cover the nature of the procedure and its consequences. 11, 12 Compared to other medical interventions, genetic testing may pose additional challenges to physicians and patients. The principles of genetics and of genetic testing may, in general, be more difficult to convey. 13 The association between risk perception and other psychological variables are key issues in the research on genetic counselling.
We evaluated participants' understanding of and perceptions about genetic testing. We also assessed to what extent their knowledge, or the lack thereof, and perceived risks influenced the levels of anxiety and depression. We hypothesized that even though couples with RM or with poor semen quality have different underlying mechanisms for their reproductive problems, PART III both undergo genetic testing and might feel the same uncertainty and psychological distress before disclosure. The main aim of this study is to examine the consequences of genetic testing before disclosure; therefore we studied both groups concurrently. Results of this study give a better insight of the impact of genetic testing and can be used to improve patient counseling before genetic testing.
METHODS AND MATERIALS

Study population and procedure
Couples with RM in whom parental karyotyping in both partners was performed or couples with poor semen quality in whom karyotyping and DNA-analysis in the male partner was performed were eligible for inclusion. RM was defined as two or more, not necessarily consecutive, miscarriages before 20 weeks of gestation. Poor semen quality was defined as a total sperm count less than 1 million spermatozoa per ejaculate.
Couples were identified between January 2006 and June 2009 in the clinical genetics laboratories of seven academic hospitals in the Netherlands. Only couples still unaware of their genetic test result were included. Exclusion criteria were: pregnancy (gestational age > 12 weeks) at time of disclosure of the genetic test result, an already identified familial genetic abnormality, a serious or life threatening disease or insufficient language proficiency. After being identified, the referring gynaecologist or urologist was contacted by the central researcher and was asked for consent to approach the couple and to determine eligibility.
Both partners of eligible couples were sent an identical questionnaire including a letter explaining the purpose of the study and asking for written informed consent. Every couple was assigned with an unique study number, identifying both partners as a couple. Following the standardized study protocol, 3 to 5 days after receiving the questionnaire the couples were contacted by telephone to provide additional information about the study. Both partners of the couple were asked to complete the questionnaire separately. A stamped return envelope was included.
Most couples had a blood draw for the genetic test 6 to 8 weeks before being contacted and a scheduled appointment for disclosure of the genetic test result 1 to 3 weeks after receiving the questionnaire. All invited couples were unaware of the results of genetic testing at the moment of returning the questionnaire.
Before study initiation, the Institutional Review Board (IRB) of the Academic Medical Center in Amsterdam had indicated that IRB approval was not needed for this study, according to the legal requirements in the Netherlands.
Pre-test counseling
In the Netherlands, pretest counseling in couples with RM or poor semen quality is provided by the gynecologist or urologist who requests the test. That health care professional is supposed to inform the couples and to mention advantages and disadvantages. In case a genetic abnormality is found, the physician ordering the test is supposed to discuss this result with the patients and to refer them to a clinical geneticist for further counseling and information. 
Study instrument
Socio-demographics and obstetric history
Participants were asked about their religion, education, occupation and obstetric history.
Knowledge and awareness
Knowledge of what is in particular tested with a genetic test, awareness of the genetic test that was performed and the information received during counseling was asked by multiple choice questions. Participants were asked to tick only one answer.
Perceived risks
Participants were asked how they perceived their risk of receiving an abnormal genetic test result, their risk of another miscarriage, a stillborn child, a child with major congenital abnormalities, their chance of conceiving at least one child and their chance of conceiving their desired number of children. Participants marked their perceived risk on visual analog PART III scales ranging from 0% to 100%. 14, 15 Participants were asked to indicate their perceived risk for each possible risk-scenario in contrast with the risk for the general population (lower, comparable or higher).
Anxiety
Anxiety was measured using the validated Dutch version of the Spielberger State-Trait Anxiety Inventory (STAI). 16, 17 The STAI consists of two subscales, the 20-item State anxiety scale and the 20-item Trait anxiety scale. The STAI differentiates between the temporary condition of "state anxiety" and the more general and long-standing quality of "trait anxiety." Responses are rated on a four point scale (1 to 4). Sum scores on this measure range from 20 to 80, with higher scores representing higher levels of anxiety. Scores on the STAI were compared to a Dutch reference population.
Depression
Depression was measured using the validated Dutch version of the 21-item second edition of the Beck Depression inventory (BDI-II). 18, 19 Respondents are asked to rate how they felt in the last two weeks. Responses are rated on a four point scale (0 to 3). Sum scores on this measure range from 0 to 63, with higher scores reflecting more depressive symptoms. A score of 0-9 indicates minimal depression, 10-18 indicates mild depression, 19-29 indicates moderate depression and 30-63 indicates severe depression. Scores on the BDI-II were compared to a Dutch reference population.
Statistical Analysis
We used the Statistical Package for the Social Sciences (SPSS 15.0) to analyze the data.
Descriptive statistics were generated to describe the total sample of participants and the subsamples of participants with RM and poor semen quality in terms of socio-demographics and obstetric history. Differences were tested with t-tests statistics and ANOVA for parametric data, and Mann-Whitney, Kruskall-Wallis and Chi 2 tests statistics for non-parametric data. could not remember the genetic test being discussed at all. In the group of men with poor semen quality the percentages were 60% and 21% respectively (table II) . In contrast, around 60% of the participants did not feel they needed any more information during their visit (58% RM, 64% poor semen quality). There were no significant statistical differences between participants with RM or poor semen quality in knowledge or awareness. Preferences for information were examined by gender. More women indicated that they preferred additional information, but this was not statistically significant (p=0.07), nor were other preferences.
The mean perceived risk of the probability of an abnormal genetic test result was 15% in both groups (figure II and III). The participants with RM estimated their risk of subsequent miscarriage around 50%. The RM group estimated their chances of conceiving at least one child (75%) much higher than the poor semen quality group (50%) (p<0.01). The individual perceived risks for all risk scenarios were highly correlated (p<0.01). The range of r s was 0.136 -0.694.
Most participants felt that their risk indicated on the different scenarios was equal to that of the general population (data not shown). There were two exceptions. The risk of another miscarriage was perceived as higher by the RM group. The chances of conceiving at least one child and conceiving the desired number of children were perceived as lower in the poor semen quality group compared to a general population. The median score on the BDI-II was 5.0 for the RM group and 3.0 for the poor semen quality group. These scores were comparable to the scores of a Dutch reference population, consisting PART III of 505 people, and were classified in the lowest category of the BDI-II 'none to minimal depression'. 19 In a logistic regression model no relations were found between any of the potential determinants and the BDI-II score.
DISCUSSION
In this study of couples undergoing genetic testing after RM or in case of poor semen quality, we found that most couples had a suboptimal knowledge of the genetic test and overestimated their risks of receiving an abnormal genetic test result before disclosure of the test result.
Women with a history of RM had higher levels of anxiety compared to a reference population and compared to women with a partner with poor semen quality. In good clinical practice it is essential that patients are well informed about the tests and procedures they are exposed to. The pre-testing information needs to be structured and concise to enable shared decision making. 9 As far as we know this is the first study to explore the perceived risks and knowledge about genetic testing in couples with RM or with poor semen quality before disclosure of the genetic test result. Although couples with RM or with poor semen quality have different underlying mechanisms for their reproductive problems, both undergo a genetic test and face the same uncertainty before disclosure.
This study was conducted in seven of the eight academic hospitals in the Netherlands, which means we invited a representative sample of patients undergoing genetic testing at outpatient clinics of gynecology because of reproductive problems. So far few studies have included men as participants, as most studied addressed only attitudes and emotional responses of women undergoing fertility treatments. [23] [24] [25] The results of our study suggest that participants did not have proper knowledge about the nature of the genetic test. They also felt they could not discuss this issue with their physician.
The exact reason for this cannot be inferred from this study. It might be that physicians do not inform their patients adequately. It is also possible that patients fail to understand the information given to them or do not remember it correctly. It is known that knowledge and understanding of genetics is low among the general public since this is often complex information. 26 More than half of participants answered that they did not need any more information at the pre-test counseling. Combining this outcome with the finding that only a minority knew about the purpose of the genetic test it seems that patients awareness of genetic counseling is low. In our study all participants overestimated their perceived risks for the different risk-scenarios presented; their risk of receiving an abnormal genetic test result, their risk of another miscarriage, a stillborn child, a child with major congenital abnormalities, their chance of conceiving at least one child and the chance of conceiving the desired number of children. This overestimation was regardless of educational status, gender or age. Most studies in hereditary cancer, such as breast and ovarian cancer, also show an overestimation of patients of perceived risks of getting cancer. 27 Whether this is a representation of a truly perceived risk, or more of a coping strategy is unclear. 27 Other studies have shown that individuals, both patients and physicians, experience difficulty in understanding probability and relative risk data. [28] [29] [30] A higher perceived risk may lead to more anxiety in patients. More realistic perceptions of the possible risk could therefore lead to less anxiety in patients. 27 On the other hand, it might also be that higher anxiety levels lead to higher perceived risks. 15 Higher perceived risks have also been linked to a lack of knowledge about the disease. 31 Research has shown that the process by which individuals construct their risks is complex, and influenced by many factors, such as environmental factors, occupation, stress and worry, in addition to their own experiences or family history factors. 27 Besides this, subfertility in itself has an enormous impact on psychological wellbeing of couples. The unfulfilled desire to have children and the possible threat of permanent infertility have been shown to lead to increased levels of depression and anxiety in women. 32 In our study, women with a history of RM were more anxious before disclosure of the genetic test result than women with a partner with poor semen quality, they recorded higher scores on both state and trait anxiety. Recurrent pregnancy loss has been described as a traumatic event, leading to symptoms of anxiety and depression and feelings of guilt. 33, 34 Maybe women with RM blame themselves for the miscarriages which can lead to increased anxiety, while women with a partner with poor semen quality do not. Women with RM may need extra attention and counseling during their consultations. Why women with RM also have higher scores on trait anxiety is unknown. This might be the result of a selection bias where women with a higher trait anxiety were more willing to participate. In contrast we did not observe higher levels of anxiety in men with poor semen quality compared to men with RM. Only a few studies have PART III focussed on the emotional wellbeing of infertile men. It has been suggested that men speak less of personal issues and, in case of poor semen quality, will keep emotional distress to themselves and that men are psychologically affected as much as women but are less open about it. 35, 36 Several limitations of our study should be considered. Firstly, the response rate in our study was about fifty percent. Only one telephone call to include eligible participants could be made, since in the study design there was little time before disclosure of the genetic test result. We have no data on the non-responders and for most of them we have no reason for not participating.
It is therefore possible that a form of selection bias occurred where participants who felt more attracted to the subject of the study were more willing to participate. Nevertheless, comparing the patient characteristics in our study to those of a large earlier study in couples with recurrent miscarriage, it seems that at least the participants in our study are a good representation of the (Dutch) clinic based population. 2 Secondly, we only have self-reported data of participants. We had no access to the medical records of participants and therefore it is unknown what information was given during the consultations by their clinicians. There is no real standardization in informing and counseling couples who undergo genetic testing.
Last but not least, although couples were asked to complete the questionnaire independently, nevertheless, it cannot be ruled out that some respondents' answers may have been influenced by their partners'.
It is important to understand why patients have a suboptimal knowledge of genetic testing and why they overestimate their genetic risk. Future research should therefore include observing the consultation process and the topics discussed and the patients' knowledge afterwards. The knowledge about genetics and genetic testing among gynecologists should also be explored.
Furthermore it would be interesting to study if patients who have realistic expectations about the genetic test and their risks experience less anxiety before disclosure of the test result and if realistic perceived risks reflect whether patients truly understand their risk.
Results of this study could be used to improve patient counseling before genetic testing, leading to well-informed patients. Potentially, this could be established if gynaecologists take more time to discuss the pros and cons of genetic testing and explain clearly the objective risks the couples have in the different outcome scenarios, such as the risk of an abnormal genetic test result or the risk of another miscarriage. The information given in these consultations should be standardized and gynaecologists probably need more training in providing genetic counselling.
Since gynaecologists have limited time per patient and are have to inform couples about other diagnostic tests (such as a hysterosalpingogram and blood tests for various antibodies) at the same moment, it might be an alternative to work with specialized counsellors providing the genetic pre-test counselling. To improve counseling in general it is important to realise that patients might not understand all the information given to them and do not always feel free to ask questions. In conclusion, improved knowledge about genetic testing in couples with recurrent miscarriage and poor semen quality is needed before a genetic test is performed. This could lead to more realistic expectations of patients about the consequences of the genetic test and to less anxiety before disclosure of the genetic test result.
